Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reiser

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Antiviral Therapy|June 9, 2006
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin, et al.
Journal of Virology|May 22, 2002
Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificitiesGeorg M Lauer, Kei Ouchi, Raymond T Chung, et al.
Gastroenterology|November 3, 2004
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsHolger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, et al.
Journal of Virology|January 25, 2008
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population levelChristoph Neumann-Haefelin, David N Frick, Jing Jing Wang, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
Detection of novel biomarkers of liver cirrhosis by proteomic analysisChristian Mölleken, Barbara Sitek, Corinna Henkel, et al.
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
Open Forum Infectious Diseases|March 15, 2016
Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled TrialStephan Ehrhardt, Nan Guo, Rebecca Hinz, et al.
Journal of Virology|September 29, 2005
Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapyGeorg M Lauer, Michaela Lucas, Joerg Timm, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Antiviral Therapy|June 9, 2006
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin, et al.
Journal of Virology|May 22, 2002
Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificitiesGeorg M Lauer, Kei Ouchi, Raymond T Chung, et al.
Gastroenterology|November 3, 2004
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsHolger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, et al.
Journal of Virology|January 25, 2008
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population levelChristoph Neumann-Haefelin, David N Frick, Jing Jing Wang, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
Detection of novel biomarkers of liver cirrhosis by proteomic analysisChristian Mölleken, Barbara Sitek, Corinna Henkel, et al.
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
Open Forum Infectious Diseases|March 15, 2016
Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled TrialStephan Ehrhardt, Nan Guo, Rebecca Hinz, et al.
Journal of Virology|September 29, 2005
Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapyGeorg M Lauer, Michaela Lucas, Joerg Timm, et al.
Pageof 3